This study was designed to examine whether endothelin is released from the intima of intact arteries, and whether endothelium-derived nitric oxide regulates its production. Endothelin was detected in the incubating medium of unstimulated pig aortae with, but not in those without endothelium. In preparations with endothelium, thrombin (2-6 U/ml) and the calcium ionophore A23187 (10' M) stimulated the release of the peptide. The basal and thrombin-stimulated production of endothelin were prevented by the protein synthetase inhibitor cycloheximide (10-' M). The production of endothelin upon stimulation with thrombin (4 U/ml) was potentiated by L-NGmonomethyl arginine and methylene blue and reduced by superoxide dismutase and 8-bromo cyclic guanosine 5'-monophosphate (GMP), while the basal release of the peptide was unaffected. Thus, (a) endothelin is released from the intimal layer of intact blood vessels, both under basal conditions and after stimulation with thrombin and the calcium ionophore A23187, and (b) endothelium-derived nitric oxide released during stimulation with thrombin inhibits the production of the peptide via a cyclic GMP-dependent pathway. (J. Clin. Invest. 1990. 85:587-590.) calcium ionophore A23187 -cyclic guanosine 5'-monophosphate * endothelium-derived relaxing factor-L-arginine pathway -thrombin
Introduction
Endothelial cells respond to a variety of stimuli by releasing vasoactive substances such as endothelium-derived relaxing and contracting factors (1, 2). Endothelium-derived relaxing factor has been identified as nitric oxide formed from L-arginine in endothelial cells (3) (4) (5) (6) . Endothelin, a 21 ,amino acid peptide purified from the medium of cultured porcine aortic endothelial cells, is a potent endothelium-derived contracting factor (7, 8) . The preproendothelin mRNA is expressed in the porcine aortic intima and in cultured porcine aortic endothelial cells (8) . In cultured cells, the expression ofthe mRNA can be stimulated by thrombin, transforming growth factor beta, bin, arginine vasopressin, angiotensin, the calcium ionophore A23 187, and phorbol esters also evoke the release of endothelin from cultured porcine and bovine endothelial cells (9, 10) . However, it remains uncertain whether intact blood vessels can produce and release the peptide under basal conditions and during stimulation. Endothelin induces potent and longlasting contractions in vivo and in vitro (8, 11, 12) . The contractions induced by endothelin can only be fully reversed by endothelium-derived nitric oxide and nitrovasodilators, but not by other agents such as calcium antagonists (13, 14) . Thus, endothelium-derived nitric oxide could act as the physiological antagonist of endothelin in the blood vessel wall.
The present experiments were designed to examine (a) whether endothelin is produced and released from the intact porcine aorta under basal conditions or upon stimulation with thrombin, and (b) whether endothelium-derived nitric oxide regulates the production and/or release of the peptide.
Methods
Blood vessels. Aortae were obtained from farm pigs killed at the nearby slaughterhouse and placed in modified Krebs-Ringer bicarbonate solution (control solution, composition in mM: NaCl 118.3, KCI 4.7, CaC12 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25.0, Ca-EDTA 0.026, and glucose 1 1.1; pH = 7.4). The blood vessels were cleaned of connective tissue and opened longitudinally. Great care was taken to preserve the intimal surface. In some experiments the endothelial layer was rubbed mechanically.
Measurement of endothelin. The blood vessels (10 cm2 intimal surface) were incubated at 37°C in 3 ml ofcontrol solution containing 0.1% BSA, aerated with a mixture of 95% 02/5% C02. To study the effects of cycloheximide, L-Nlmonomethyl arginine (L-NMMA)', methylene blue, SOD, or 8-bromo cyclic guanosine 5'-monophosphate (cGMP) on the production of endothelin upon stimulation with thrombin, the blood vessels were incubated for 15 4 h incubation. In all experiments n is the number of pigs from which the aortae were taken. Each sample was measured in duplicate. Statistical evaluation ofthe data was performed using the t test for paired observations and Scheffe's test for multiple comparisons. Differences were considered significant at P < 0.05.
Results

Production ofendothelin
Basal production. The basal production of endothelin by the porcine aorta was detected in preparations with, but not in those without endothelium after 4 h incubation (n = 3, P < 0.05; Fig. 1 ). No detectable amounts of endothelin were observed after 1 or 2 h incubation. Cycloheximide (10-6 M), a protein synthetase inhibitor, markedly inhibited the basal production of endothelin, from 49 ± 8 to 12 ± 7 pg/cm2 intimal surface (n = 4, P < 0.05).
Thrombin. Thrombin stimulated the basal production of endothelin in a concentration-dependent manner in preparations with (n = 7, P < 0.05; Fig. 2 ), but not in those without endothelium (n = 3; amount not detectable). The effect of thrombin was maximal at 4 U/ml. No detectable amount of endothelin was observed after 1 or 2 h stimulation with thrombin (4 U/ml). Cycloheximide (10-6) reduced the production of the peptide upon stimulation with thrombin (4 U/ml) from 83± 10 pg/cm2 intimal surface, to values below the limit of detection (n = 4, P < 0.05).
Calcium ionophore A23187. The calcium ionophore A23187 (10-6 M) stimulated the release ofendothelin after 4 h incubation, from 30 ± 5 to 132 ± 3 pg/cm2 intimal surface (n = 4, P < 0.05). The calcium ionophore A23187 (10-6 M) did not release detectable amounts of endothelin from preparations without endothelium (n = 3).
Endothelium-derived nitric oxide and production ofendothelin L-NMMA (2 X 10-4 M) augmented the thrombin-stimulated, of immunoreactive (ir) endothelin per square centimeter of intimal surface after 4 h incubation (n = 7). Thrombin (up to 8 U/ml) did not release detectable amounts of endothelin in preparations without endothelium (n = 3). * Indicates a significant difference as compared with control (P < 0.05).
with endothelium (n = 8, P < 0.05; Fig. 3 ). D-20-Monomethyl arginine (2 X 10-4 M) did not modify the basal and thrombinstimulated production of endothelin (n = 4; data not shown). Methylene blue (10-5 M) did not significantly modify the basal production of endothelin; however, it stimulated that induced by thrombin (4 U/ml) (n = 6, P < 0.05; Fig. 4 ). SOD (250 U/ml) did not influence the basal production of the peptide (control, 41 ± 7; SOD, 31 ± 9 pg/cm2 intimal surface; n = 6), but inhibited that upon stimulation with thrombin (4 U/ml) (n = 6, P < 0.05; Fig. 5 ). Similarly, 8 -bromo cGMP (l0-3 M) did not affect the basal release of endothelin (control, 44 ± 3.5; 8-bromo cGMP, 50 ± 3 pg/cm2 intimal surface; n = 6), but decreased the production ofthe peptide upon stimulation with thrombin (4 U/ml) (n = 6, P < 0.05; Fig. 5 ).
Discussion
The present experiments demonstrate that endothelin is released not only from cultured cells, but also from intact blood vessels in an endothelium-dependent manner. The peptide is produced both under basal conditions and after stimulation with thrombin or the calcium ionophore A23187. Endothelium-derived nitric oxide inhibits the formation of endothelin via a cGMP-dependent mechanism.
The fact that the production of endothelin is endothelium dependent is in agreement with the expression of preproendothelin mRNA in cultured porcine endothelial cells, but not in cultured porcine vascular smooth muscle cells (8) . The expression ofpreproendothelin mRNA has also been observed in the intimal layer of the pig aorta (8) . This study demonstrates that endothelin is indeed released under basal conditions from the intact aorta of the pig, and can be stimulated by thrombin and the calcium ionophore A23187. The production of the peptide produced is expressed as picograms immunoreactive (ir) endothelin released per square centimeter intimal surface after 4 h incubation. * Indicates a significant difference as compared with control; + indicates a significant difference of preparations stimulated with thrombin in the presence and absence of methylene blue (P < 0.05).
peptide requires de novo protein synthesis, since the protein synthetase inhibitor cycloheximide markedly inhibited the release ofthe peptide in control and thrombin-stimulated preparations. The time course of the production of endothelin induced by thrombin in the porcine aorta also is compatible with a stimulation of the production of the peptide rather than its release from intracellular stores (8).
Thrombin not only stimulates the production of endothelin, but also releases endothelium-derived relaxing factor in a variety ofblood vessels (15-18). Endothelium-derived relaxing factor has been identified as nitric oxide (3) (4) (5) ; the amino acid L-arginine is the precursor of nitric oxide in endothelial cells (6) . The production of nitric oxide from cultured endothelial cells and from the endothelium ofisolated blood vessels can be inhibited stereospecifically by L-NMMA, which is a false substrate for the enzyme synthesizing nitric oxide (6, 19) . Nitric oxide activates soluble guanylate cyclase and in turn increases cGMP levels in endothelial and vascular smooth muscle cells (20) (21) (22) (23) (24) . In the porcine aorta, the production of endothelin upon stimulation with thrombin was potentiated by L-NMMA and by methylene blue, an inhibitor of soluble guanylate cyclase (25, 26) . In addition, SOD, a scavenger of superoxide anions that inactivate endothelium-derived nitric oxide (27, 28), and 8-bromo cGMP, a nonhydrolyzable analogue of cGMP, reduced the production of endothelin induced by thrombin. These results indicate that during stimulation with thrombin, endothelium-derived nitric oxide inhibits the production ofendothelin. The inhibitory effects of nitric oxide on the production of endothelin must be mediated by a cGMPdependent pathway, since the inhibitor of soluble guanylate cyclase methylene blue increased, and the nonhydrolyzable analogue of cGMP lowered the thrombin-stimulated production of the peptide.
In contrast, the basal production of endothelin was not affected by L-NMMA, methylene blue, SOD, or 8-bromo cGMP. This suggests that under basal conditions very little endothelium-derived nitric oxide is produced, or that a relaxing factor different from nitric oxide is released. The latter interpretation is in line with the fact that in perfused cultured porcine aortic endothelial cells nitric oxide does not account for endothelium-dependent relaxations occurring under basal conditions (29). The inability of 8-bromo cGMP to inhibit the basal production of endothelin further indicates that the spontaneous formation of the peptide is insensitive to modulation by endothelium-derived nitric oxide. This explanation is reinforced by the fact that the thrombin-induced production of endothelin could not be inhibited by SOD or by 8-bromo cGMP to a level below the amount of peptide released under control conditions.
The inhibition ofthe production ofendothelin by endothelium-derived nitric oxide might have important physiological and pathophysiological implications. Endothelium-derived nitric oxide plays a major role in the regulation of vascular tone and platelet function (1, (30) (31) (32) (33) ; besides its direct effects on smooth muscle, the inhibitory effects of endothelium-derived nitric oxide on the endothelin production represent a new mechanism ofaction whereby the endogenous nitrate can affect vascular tone. In arteries with regenerated endothelium, hyperlipidemia, hypertension, and atherosclerosis, the release of endothelium-derived nitric oxide is impaired (34) (35) (36) (37) (38) ).
An impaired release of endothelium-derived nitric oxide in diseased arteries may lead to an enhanced endothelin production. The reduced release of endothelium-derived nitric oxide favors local platelet activation (32, 33, 35, 39) . Thrombin and transforming growth factor beta, which are abundantly present under these conditions (40, 41) , would stimulate the production of endothelin, unopposed by the endogenous nitric oxide. This may contribute importantly to the occurrence ofspasm in diseased blood vessels.
